Don't Just Read the News, Understand It.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Heatwaves
Artificial Intelligence
Social Media
Stock Markets
Natural Disasters
World Cup
UK Economy
South America
Trade
Innovation
Donald Trump
Agriculture
Published • loading... • Updated

Aurinia Pharmaceuticals to Host Conference Call to Discuss AUR200 Phase 1 Study Results on June 30, 2025

Summary by Financial Post
Open the article to view the coverage from Financial Post

4 Articles

All
Left
1
Center
Right
1
Enid News & EagleEnid News & Eagle
+2 Reposted by 2 other sources
Lean Left

Aurinia Pharmaceuticals to Host Conference Call to Discuss AUR200 Phase 1 Study Results on June 30, 2025

ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)--Jun 29, 2025-

Read Full Article
stocktitan.netstocktitan.net

Aurinia Pharmaceuticals Readies First Human Trial Data for Novel Drug AUR200: Key Results Coming Tomorrow

First-ever human trial results for Aurinia's innovative AUR200 drug program to be unveiled. Join live presentation for exclusive Phase 1 data insights.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources lean Right
50% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

stocktitan.net broke the news in on Sunday, June 29, 2025.
Sources are mostly out of (0)

Similar News Topics

Pharma icon

Pharma

Rockville, Maryland icon

Rockville, Maryland

News
For You
SearchBlindspotLocal